Overview

A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief

Status:
Terminated
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect information about how patients feel when doctors manage their pain after lumbar spine surgery using a combination of EXPAREL® and bupivacaine injected into the lumbar spine at the end of surgery, compared to the patients that doctors use only EXPAREL® or bupivacaine to manage their pain. This information will help doctors determine which approach works best for patients who will receive surgery in their lumbar spine in the future.
Phase:
Phase 4
Details
Lead Sponsor:
Virtua Health, Inc.
Treatments:
Bupivacaine